HIMS

Hims & Hers Health Inc. (NYSE: HIMS) is a telehealth company that connects consumers to licensed healthcare professionals, offering a range of prescription and non-prescription health and wellness products. Founded in 2017 and headquartered in San Francisco, California, the company focuses on providing accessible care for various conditions, including sexual health, hair loss, dermatology, and mental health. Hims & Hers aims to simplify the healthcare experience by offering online consultations and personalized treatments delivered directly to customers. ​

Over the past 52 weeks, Hims & Hers' stock has traded between a low of $11.20 and a high of $72.98. ​

Analyst sentiment toward Hims & Hers is mixed. According to The Wall Street Journal, out of 17 analysts, 6 recommend a "Buy," 9 suggest "Hold," and 1 advises "Sell," with an average price target of $45.88. ​Seeking Alpha+20barrons.com+20businessinsider.com+20The Wall Street Journal

Subscribe to our API. See Strong Buy and Sell Signals the Day after They Occur!